Table 4.
Specific lysis of targets (%)
|
||||||
---|---|---|---|---|---|---|
CD4−CD8+ (%)†
|
MC57 H-2b
|
DBA1 H-2b
|
||||
CD4−CD8+V α 2+(%)
|
p33
|
Nor.
|
p118
|
Nor.
|
||
Mouse* | Naive blood | d7 LCMV spleen | ||||
nu/nu | <0.1 | 0.5 | 9 | 5 | 9 | <1 |
TCR 318+ | <0.1 | 0.1 | 3 | 9 | 7 | <1 |
H-2q/q | <1 | 2 | 3 | <1 | ||
1 | 1 | 2 | <1 | |||
nu/nu | <0.1 | 0.6 | 9 | 10 | 5 | <1 |
TCR 318+ | <0.1 | 0.1 | 7 | 10 | 7 | <1 |
H-2q/q | 6 | 5 | 4 | <1 | ||
5 | 7 | 5 | <1 | |||
nu/nu | 0.9 | 13.4 | 65 | 16 | 10 | 10 |
TCR 318+ | 0.7 | 12.8 | 55 | 14 | 14 | 6 |
H-2b/q | 23 | 7 | 10 | <1 | ||
14 | 6 | 7 | <1 | |||
nu/nu | 1.5 | 9.4 | 73 | 17 | 16 | 18 |
TCR 318+ | 1.1 | 8.7 | 47 | 15 | 18 | 10 |
H-2b/q | 25 | 6 | 10 | 6 | ||
9 | 1 | 2 | <1 | |||
Controls: | ||||||
ICR | 8.0 | 18.2 | 16 | 15 | 65 | <1 |
H-2q/q | 0.5 | 0.6 | 10 | 7 | 70 | <1 |
C57BL/6 | 12.2 | 50.4 | 100 | 10 | 15 | 15 |
H-2b/b | 1.1 | 4.5 | 93 | 10 | 16 | 18 |
TCR 318 | 15.4 | 28.4 | 44 | 12 | 14 | 15 |
H-2b/b | 8 | 18 | 24 | 4 | 9 | 2 |
Significant values are bold. Nor., normal targets.
Mice were infected i.v. with 102 pfu of LCMV-WE and CTL activity tested in a standard 51Cr release assay. Spontaneous release was <15% on MC57 and <20% on DBA 1 targets; the % lysis figures shown are for 90, 30, 10, and 3:1 or 90, 30:1 target cells from top to bottom.
The results are expressed as % of living nucleated cells and are representative of 8 H-2q/q and 10 H-2b/q nude tg TCR+ mice tested. LCMV immune spleen cells from euthymic nu/+TCR 318 H-2q/q mice lysed p 33 MC57 targets tested at 5, 1, 1, or 1% vs. normal MC57 6, 4, 1, or 1%, p118 DBA1 targets to 91, 92, 67, 42% vs. normal DBA1 targets 11, 18, 17, or 16%. Thus there is no relevant positive selection of functional tgTCR on H-2q (see also Fig. 1).